Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023 Carlos Abud-Mendoza; Francisco Javier Aceves-Ávila; César Alejandro Arce-Salinas; José Álvarez Nemegyei; Leonor Barile-Fabris; Sergio Durán-Barragán; Diana Elsa Flores-Alvarado; Eufrates Hernández-Núñez; Fedra Irazoque-Palazuelos; José Francisco Moctezuma-Ríos; Virginia Pascual-Ramos; Margarita Portela-Hernández; Luis Humberto Silveira; Lilia Andrade-Ortega; Ana Barrera-Vargas; Sandra Carrillo-Vázquez; Zully Castro-Colin; Enrique Cuevas-Orta; Luis Felipe Flores-Suárez; Guillermo Arturo Guaracha-Basáñez; María Fernanda Hernández-Cabrera; Iván de Jesús Hernández-Galarza; David Alejandro Herrera-vanOostdam; Adriana Concepción Lobato-Belmonte; Laura Aline Martínez-Martínez; Marco Ulises Martínez-Martínez; Gabriel Medrano-Ramírez; Francisco Javier Merayo-Chalico; Graciela Meza-López y Olguín; Francisco Olan; Genaro Peña-Santos; César Ramos-Remus; Greta Reyes-Cordero; Vijaya Rivera-Terán; Jorge Rojas-Serrano; Griselda Serna-Peña; Sandra Sicsik-Ayala; César Armando Sifuentes-Cantú; David Vega-Morales; Pablo Villaseñor-Ovies; Daniel Xibillé-Friedmann; César Pacheco-Tena;

Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies Paloma de Abreu; Gabriela Ávila-Pedretti; Zoilo Morel; María Isabel Acosta; Sonia Cabrera-Villalba; Patricia Melgarejo; Marcos Franco; Pedro Delgadillo; Lourdes Román; Juan Gabriel Elizaur; Ernesto Paredes; Darwin Octavio Cordobilla; Daniel Palleiro; Miguel Albanese; Julio Mazzoleni;

Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;